Using Simulated Data to Assess Case-Crossover Designs for Studying Less Transient Effects of Drugs Malcolm Maclure Commentary 03 June 2017 Pages: 757 - 760
Potential Teratogenic Effects of Clomiphene Citrate Alessandra ScaparrottaFrancesco ChiarelliAlberto Verrotti Review Article 25 May 2017 Pages: 761 - 769
Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies Lauren HirschJaeun YangTamara Pringsheim Systematic Review 05 June 2017 Pages: 771 - 781
The Incidence of Drug- and Herbal and Dietary Supplement-Induced Liver Injury: Preliminary Findings from Gastroenterologist-Based Surveillance in the Population of the State of Delaware Maricruz VegaManisha VermaFor the Drug Induced Liver Injury Network (DILIN) short communication 29 May 2017 Pages: 783 - 787
Evaluation of the Case–Crossover (CCO) Study Design for Adverse Drug Event Detection Zachary BurninghamTao HeBrian C. Sauer Original Research Article 04 May 2017 Pages: 789 - 798
An Algorithm to Identify Generic Drugs in the FDA Adverse Event Reporting System Geetha IyerSathiya Priya MarimuthuSonal Singh Original Research Article 07 June 2017 Pages: 799 - 808
Role of Medicines of Unknown Identity in Adverse Drug Reaction-Related Hospitalizations in Developing Countries: Evidence from a Cross-Sectional Study in a Teaching Hospital in the Lao People’s Democratic Republic Céline CailletChanvilay SichanhAnne Roussin Original Research Article Open access 20 May 2017 Pages: 809 - 821
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping Ippazio Cosimo AntonazzoEmanuel RaschiElisabetta Poluzzi Original Research Article 09 June 2017 Pages: 823 - 834
Macrolides, Digoxin Toxicity and the Risk of Sudden Death: A Population-Based Study Kieran L. QuinnErin M. MacdonaldFor the Canadian Drug Safety and Effectiveness Research Network (CDSERN) Original Research Article 18 April 2017 Pages: 835 - 840